Giant cell arteritis (GCA), formerly known as temporal arteritis, was first described by Mayo Clinic doctors and classified as an inflammatory condition of the blood vessels in the early to mid-20th ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved upadacitinib to treat adults with giant cell arteritis. It is the second drug to be ...

Please provide your email address to receive an email when new articles are posted on . Earlier diagnosis can improve outcomes in giant cell arteritis. Integrating imaging can improve diagnostic ...